Overview
Dr. Leung obtained her undergraduate degree in biochemical sciences from Harvard University. While attending medical school at Duke University, she completed a year-long research fellowship studying genetic markers of late-onset Alzheimer’s disease at the National Institute on Aging as part of the NIH Clinical Research Training Program. She completed her neurology residency and clinical neurophysiology fellowship at Stanford University Medical Center, and is currently a Ph.D. candidate in the graduate training program in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Leung joined the Center for Genetic Muscle Disorders at the Kennedy Krieger Institute as a translational research fellow in 2010 and was appointed to the faculty in 2014. Her clinic specializes in electromyography and the diagnosis and treatment of hereditary muscle diseases. Dr. Leung’s research focuses on the development of imaging biomarkers and outcome measures for muscle diseases. She is the principal investigator for a longitudinal cohort study of whole-body MRI in facioscapulohumeral muscular dystrophy. Dr. Leung is also a site principal investigator for the Ionis-DMPKRx trial, a phase Ib/IIa clinical trial of a novel RNA-based therapy for myotonic muscular dystrophy.
Dr. Leung is rated as an Experienced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. Her top areas of expertise are Facioscapulohumeral Muscular Dystrophy (FSHD), Dysferlinopathy, Limb-Girdle Muscular Dystrophy Type 2I, and Limb-Girdle Muscular Dystrophy.
Her clinical research consists of co-authoring 47 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1741 Ashland Avenue, Room 847, Room 847, Baltimore, MD 21205
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
Johns Hopkins Outpatient Center
Dr. Tom Crawford has been a member of the Department of Neurology since 1987. He is co-director of the MDA clinic for Neuromuscular Disorders and Neurologist for the Ataxia Telangiectasia Clinical Center at Johns Hopkins. His practice involves general child neurology with a principal interest in caring for children with neuromuscular, neuromotor, and ataxic disorders. Primary research interests involve the basic science and clinical characterization of two important neurologic disorders that affect children: Spinal Muscular Atrophy and Ataxia Telangiectasia. He is also actively involved in the Biology of neurofilaments by characterization of transgenic animal models. He is on the Medical and Scientific Advisory Boards of Families of Spinal Muscular Atrophy, and the Medical Advisory Committee for the Muscular Dystrophy Association. He is the Neurologist for the Ataxia Telangiectasia Clinical Center at Johns Hopkins, which has evaluated almost half of the known patients with this disorder in the United States. Additional specific clinical interests include evaluation and treatment of children with brachial plexus palsies. Dr. Crawford received his medical degree from the University of Southern California. He completed a pediatric internship and residency at the Pediatric Pavilion of the Los Angeles County / University of Southern California Medical Center, followed by a pediatric chief residency. He completed his training in Neurology with Special Qualification in Child Neurology at the Los Angeles Childrens Hospital. He then traveled east to the laboratory of Dr John Griffin at Johns Hopkins for a fellowship in Neuromuscular Disorders. Prior to medical training and Neurology residency, he majored in Psychology and Religion at Yale College. Dr. Crawford has published extensively and presented nationally and internationally. He has an active role in teaching medical students and residents in neurology. In addition, Dr. Crawford has special interest and experience in EMG studies of children and adults. Dr. Crawford is rated as a Distinguished provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. His top areas of expertise are Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), Ataxia-Telangiectasia, and Spinal Muscular Atrophy Type 2.
Neurology Center Of Fairfax LTD.
Robert Kurtzke is a Neurologist in Fairfax, Virginia. Dr. Kurtzke is rated as an Advanced provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. His top areas of expertise are Spinal Muscular Atrophy Type 2, X-Linked Infantile Spinal Muscular Atrophy, Spinal Muscular Atrophy with Arthrogryposis, Post Polio Syndrome, and Nerve Decompression.
Kathryn Wagner is a Neurologist in Baltimore, Maryland. Dr. Wagner is rated as a Distinguished provider by MediFind in the treatment of Spinal Muscular Atrophy Type 2. Her top areas of expertise are Limb-Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 1B, Limb-Girdle Muscular Dystrophy Type 1A, and Limb-Girdle Muscular Dystrophy Type 2I.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Facioscapulohumeral Muscular Dystrophy (FSHD)
- Distinguished
- Duchenne Muscular DystrophyDr. Leung isDistinguished. Learn about Duchenne Muscular Dystrophy.
- DysferlinopathyDr. Leung isDistinguished. Learn about Dysferlinopathy.
- Limb-Girdle Muscular DystrophyDr. Leung isDistinguished. Learn about Limb-Girdle Muscular Dystrophy.
- Limb-Girdle Muscular Dystrophy Type 2IDr. Leung isDistinguished. Learn about Limb-Girdle Muscular Dystrophy Type 2I.
- Myotonic DystrophyDr. Leung isDistinguished. Learn about Myotonic Dystrophy.
- Myotonic Dystrophy Type 2Dr. Leung isDistinguished. Learn about Myotonic Dystrophy Type 2.
- Advanced
- Coenzyme Q Cytochrome C Reductase Deficiency
- DystrophinopathyDr. Leung isAdvanced. Learn about Dystrophinopathy.
- Glycogen Storage Disease Type 5Dr. Leung isAdvanced. Learn about Glycogen Storage Disease Type 5.
- Limb-Girdle Muscular Dystrophy Type 1A
- Limb-Girdle Muscular Dystrophy Type 1B
- Limb-Girdle Muscular Dystrophy Type 2A
- Experienced
- Angelman SyndromeDr. Leung isExperienced. Learn about Angelman Syndrome.
- Becker Muscular DystrophyDr. Leung isExperienced. Learn about Becker Muscular Dystrophy.
- Benign Autosomal Dominant MyopathyDr. Leung isExperienced. Learn about Benign Autosomal Dominant Myopathy.
- Central Core DiseaseDr. Leung isExperienced. Learn about Central Core Disease.
- Centronuclear MyopathyDr. Leung isExperienced. Learn about Centronuclear Myopathy.
- Collagen VI-Related MyopathyDr. Leung isExperienced. Learn about Collagen VI-Related Myopathy.